Tyler G Ketterl, MD, MS
Cancer and Blood Disorders Center, Neuroblastoma Program, Bone Tumors and Soft Tissue Tumors, Adolescent and Young Adult Cancer Program, Fertility Preservation Program, Thyroid Program, I-131-MIBG Therapy, Solid Tumors Oncology
On staff since December 2017
Children's Title: Medical Director, Adolescent and Young Adult Oncology, Cancer and Blood Disorders Center
Academic Title: Assistant Professor, Hematology-Oncology
Research Center: Ben Towne Center for Childhood Cancer Research
Tyler G. Ketterl, MD, MS is an attending physician at Seattle Children’s Hospital and Assistant Professor at the University of Washington School of Medicine. Dr. Ketterl is the Medical Director of the Adolescent and Young Adult Oncology Program. Dr. Ketterl holds triple board certifications in Internal Medicine, Pediatrics and Pediatric Hematology/Oncology. He completed his Internal Medicine and Pediatrics Residency at the University of Minnesota, Pediatric Hematology/Oncology fellowship at the University of Washington, and his Masters in Science in Epidemiology with a focus on clinical research methods at the University of Washington.
In July of 2018, Dr. Ketterl joined the faculty at Seattle Children’s Hospital and the University of Washington. Dr. Ketterl’s work currently focuses on the long-term impact of cancer therapy on adolescent and young adult survivors of cancer. Of particular interest to Dr. Ketterl is developing interventions that could prevent early morbidity and mortality from type 2 diabetes and cardiovascular disease in adolescent and young adult survivors of cancer.
Dr. Ketterl also has interest and expertise in germ cell tumors and fertility preservation methods.
Dr Ketterl is wonderful! Always explains everything in detail. Is very helpful and takes time with the patients.
Award Name Award Description Awarded By Award Date SEATTLE TOP DOCTOR - 2022 Seattle Magazine 2022 Transdsicipinary Research on Energetics and Cancer Research Education Program Fellow The NCI Funded TREC Training Workshop fellows are appointed for a one-year term, beginning with the week-long in-person Training Workshop followed by 12-months of mentored guidance by a course faculty member. Fellows join a scholarly network of peer fellows, course faculty, and investigators from the prior TREC initiative and previous TREC workshops. Through this experience and via connections with the wider community of TREC-inspired researchers, fellows develop their own transdisciplinary expertise and increased scholarly output in TD science in energetics and cancer. Yale School of Public Health June 2020 - June 2021 American Society of Transplant and Cellular Therapy Clinical Research Training Course Scholar American Society of Transplant and Cellular Therapy 2019 - 2020 Clinical Research Scholars Program Scholar The Clinical Research Scholars Program (CRSP) is a mentored research career development program for CCTR investigators. The program objective is to support junior faculty in the development of successful clinical, translational and outcomes research at Seattle Children’s. This goal is accomplished through a structured program of mentoring by dedicated CRSP Faculty, educational seminars, and financial support. Seattle Children's Research Institute 2018 - 2020 Young Investigator Award Conquer Cancer Foundation of American Society of Clinical Oncology July 1, 2018 - June 30, 2019 Conquer Cancer Foundation of American Society of Clinical Oncology Merit Award Conquer Cancer Foundation of American Society of Clinical Oncology June 2018 Outstanding Presentation Award, Fellow and Resident Research Day Seattle Childrens Hospital and University of Washington School of Medicine May 2017 Alberta Corkery Fellowship Travel Award Seattle Children's Hospital Feb. 2017 Edna Ittner Medical Scholarship University of Nebraska Medical Center Aug. 2010 Margaret R. Noel Scholarship University of Nebraska Medical Center Aug. 2009 Milton F. Arnholdt Memorial Scholarship University of Nebraska Medical Center Aug. 2007
Manuscripts in Refereed Journals
GBD 2019 Adolescent Young Adult Cancer Collaborators.The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
34871551 The Lancet. Oncology, 2022 Jan. : 23(1)27-52 PMCID:PMC8716339
Ketterl TG, Ballard S, Bradford MC, Chow EJ, Jenssen K, Myers S, Rosenberg AR, Van Doren M, Baker KSFeasibility and acceptability of a home-based resistance training intervention in adolescent and young adult hematopoietic cell transplant survivors.
34260139 Pediatric blood & cancer, 2021 Nov. : 68(11)e29206 PMCID:PMC8463478
Field MT, Lamble AJ, Holtzclaw SL, Tucker SA, Ketterl TGChemotherapy roadmaps in pediatric oncology: A digital electronic medical record integrated solution.
34558367 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021 Sept. 24 : 10781552211040450
Ketterl TGClosing the Gaps: Progress in the Care of Adolescents and Young Adults With Cancer.
34010020 JCO Oncology Practice, 2021 June : 17(6)302-304
Woodruff TK, Ataman-Millhouse L, Acharya KS, Almeida-Santos T, Anazodo A, Anderson RA, Appiah L, Bader J, Becktell K, Brannigan RE, Breech L, Bourlon MT, Bumbuliene Å½, Burns K, Campo-Engelstein L, Campos JR, Centola GM, Chehin MB, Chen D, De Vos M, Duncan FE, El-Damen A, Fair D, Famuyiwa Y, Fechner PY, Fontoura P, Frias O, Gerkowicz SA, Ginsberg J, Gracia CR, Goldman K, Gomez-Lobo V, Hazelrigg B, Hsieh MH, Hoyos LR, Hoyos-Martinez A, Jach R, Jassem J, Javed M, Jayasinghe Y, Jeelani R, Jeruss JS, Kaul-Mahajan N, Keim-Malpass J, Ketterl TG, Khrouf M, Kimelman D, Kusuhara A, Kutteh WH, Laronda MM, Lee JR, Lehmann V, Letourneau JM, McGinnis LK, McMahon E, Meacham LR, Mijangos MFV, Moravek M, Nahata L, Ogweno GM, Orwig KE, Pavone ME, Peccatori FA, Pesce RI, Pulaski H, Quinn G, Quintana R, Quintana T, de Carvalho BR, Ramsey-Goldman R, Reinecke J, Reis FM, Rios J, Rhoton-Vlasak AS, Rodriguez-Wallberg KA, Roeca C, Rotz SJ, Rowell E, Salama M, Saraf AJ, Scarella A, Schafer-Kalkhoff T, Schmidt D, Senapati S, Shah D, Shikanov A, Shnorhavorian M, Skiles JL, Smith JF, Smith K, Sobral F, Stimpert K, Su HI, Sugimoto K, Suzuki N, Thakur M, Victorson D, Viale L, Vitek W, Wallace WH, Wartella EA, Westphal LM, Whiteside S, Wilcox LH, Wyns C, Xiao S, Xu J, Zelinski MA View from the past into our collective future: the oncofertility consortium vision statement.
33405006 Journal of assisted reproduction and genetics, 2021 Jan. : 38(1)3-15 PMCID:PMC7786868
Ketterl TG, Latham GJPerioperative Cardiothoracic and Vascular Risk in Childhood Cancer and its Survivors.
32360009 Journal of cardiothoracic and vascular anesthesia, 2021 Jan. : 35(1)162-175
Chow EJ, Doody DR, Di C, Armenian SH, Baker KS, Bricker JB, Gopal AK, Hagen AM, Ketterl TG, Lee SJ, Reding KW, Schenk JM, Syrjala KL, Taylor SA, Wang G, Neuhouser ML, Mendoza JAFeasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial.
33037989 Journal of cancer survivorship : research and practice, 2020 Oct. 10 : PMCID:PMC8035343
Fladeboe KM, Scott S, Bradford MC, Ketterl TG, Yi-Frazier JP, Rosenberg ARSexual Activity and Substance Use Among Adolescents and Young Adults Receiving Cancer Treatment: A Report from the PRISM Randomized Controlled Trial.
32316824 Journal of adolescent and young adult oncology, 2020 Oct. : 9(5)594-600 PMCID:PMC7578176
Ketterl TG, Syrjala KL, Casillas J, Jacobs LA, Palmer SC, McCabe MS, Ganz PA, Overholser L, Partridge A, Rajotte EJ, Rosenberg AR, Risendal B, Rosenstein DL, Baker KSLasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors.
30707763 Cancer, 2019 June 1 : 125(11)1908-1917 PMCID:PMC6508988
Ketterl TG, Dundas NJ, Roncaioli SA, Littman AJ, Phipps AIAssociation of Pre-pregnancy BMI and Postpartum Weight Retention Before Second Pregnancy, Washington State, 2003-2013.
29512055 Maternal and child health journal, 2018 Sept. : 22(9)1339-1344 PMCID:PMC6077101
Ketterl TG, Wu D, Fromm JR, Soma L, Dahlberg AE, Wood BL, Tarlock KDonor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia.
29269802 Bone marrow transplantation, 2018 March : 53(3)352-355 PMCID:PMC5936635
Ketterl TG, Chow EJ, Leisenring WM, Goodman P, Koves IH, Petryk A, Steinberger J, Baker KSAdipokines, Inflammation, and Adiposity in Hematopoietic Cell Transplantation Survivors.
29197678 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018 March : 24(3)622-626 PMCID:PMC5831197
Rosenberg AR, Bona K, Ketterl T, Wharton CM, Wolfe J, Baker KSIntimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study.
27769762 The Journal of Adolescent Health : Official publication of the Society for Adolescent Medicine, 2017 Jan. : 60(1)93-99 PMCID:PMC5228591
Langereis EJ, den Os MM, Breen C, Jones SA, Knaven OC, Mercer J, Miller WP, Kelly PM, Kennedy J, Ketterl TG, O'Meara A, Orchard PJ, Lund TC, van Rijn RR, Sakkers RJ, White KK, Wijburg FAProgression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
26935461 The Journal of bone and joint surgery. American volume, 2016 March 2 : 98(5)386-95 PMCID:26935461
Ketterl TG, Messinger YH, Niess DR, Gilles E, Engel WK, Perkins JLOfatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
23813921 Pediatric blood and cancer, 2013 Dec. : 60(12)E163-5 PMCID:23813921
Presentations Title Event Location Date Impact of cancer on employment and finances in young adult (YA) survivors American Society of Clinical Oncology Annual Meeting Chicago, IL June 2018 Adipokines, Inflammation and Adiposity in Hematopoietic Cell Transplant Survivors American Society for Blood and Marrow Transplantation Tandem Meeting Orlando, FL Feb. 2017
Grant Title Grantor Amount Award Date AHEAD Study: Assessing Health Electronically for Adolescent and Young Adult Oncology Patients Seattle Children’s Cancer and Blood Disorders Center Research Pilot Fund $64,496 2020 - 2022 Pilot Study of a Resistance Training Intervention in Adolescent and Young Adult Hematopoietic Cell Transplant Survivors Seattle Childrens Hospital Center for Clinical and Translational Research Clinical Research Scholars Program $67,325 Oct. 1, 2018 - Sept. 30, 2020 Feasibility of a Resistance Training Intervention in Adolescent and Young Adult Hematopoietic Cell Transplant Survivors Conquer Cancer Foundation of ASCO Investigator Award $50,000 July 1, 2018 - June 30, 2019 NIH T32 Training Grant NIH Aug. 1, 2016 - June 30, 2018
- Board Certification(s)
- Medical/Professional School
University of Nebraska College of Medicine, Omaha, NE
University of Washington, Seattle, WA
University of Minnesota at Minneapolis, Minneapolis, MN
University of Washington School of Medicine GME, Seattle, WA
- Clinical Interests
- Adolescent and Young Adult Oncology
- Germ Cell Tumors
- Solid Tumors
- Fertility Preservation
- Research Description
- Long-term impact of cancer therapy on adolescent and young adult survivors of cancer
- Metabolic Syndrome
- Sarcopenic Obesity
- Exercise Interventions for Cancer Survivors
- Risk Behavior Screening in AYA Cancer Patients
- Research Focus Area
Cancer biology, Metabolic Syndrome, Cancer